Phase I PK study of budesonide/albuterol delivered from PT027 in healthy Chinese participants.

Trial Identifier:	D6935C00001
Sponsor:	AstraZeneca
Start Date:	August 2024
Primary Completion Date:	September 2024
Study Completion Date:	September 2024
Condition:	Healthy Volunteers

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language	Description
	English Version
	Simplified Chinese (China) Translation

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
CN	Shanghai, CN, 200031

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.